๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Eli Lilly Nederland B.V. โ€” Licensed Medicines

98 medicines held by Eli Lilly Nederland B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 98 products held by Eli Lilly Nederland B.V.
MedicineActive substanceLicence holderStatus
100 units/mL Tempo Pen solution for injection in pre-filled pen
EU/1/20/1422/016-017
Insulin lispro Eli Lilly Nederland B.V. โ€”
200 units/mL KwikPen solution for injection in pre-filled pen
EU/1/20/1422/013-015
Insulin lispro Eli Lilly Nederland B.V. โ€”
ABASAGLAR 100 units/mL solution for injection in a cartridge
EU/1/14/944/001-004
Insulin glargine Eli Lilly Nederland B.V. โ€”
ABASAGLAR 100 units/mL solution for injection in a pre-filled pen
EU/1/14/944/005-008
Insulin glargine Eli Lilly Nederland B.V. โ€”
Adcirca (previously Tadalafil Lilly)
EU/1/08/476/001-004
Tadalafil Eli Lilly Nederland B.V. โ€”
Adcirca 20 mg film-coated tablets
EU/1/08/476/005-06
Tadalafil Eli Lilly Nederland B.V. โ€”
Alimta
EU/1/04/290/002
Pemetrexed Eli Lilly Nederland B.V. โ€”
Alimta 500 mg powder for concentrate for solution for infusion
EU/1/04/290/001
Pemetrexed Eli Lilly Nederland B.V. โ€”
Amyvid 1,900 MBq/mL solution for injection
EU/1/12/805/003-004
Florbetapir (18f) Eli Lilly Nederland B.V. โ€”
Amyvid 800 MBq/mL solution for injection
EU/1/12/805/001-002
Florbetapir (18f) Eli Lilly Nederland B.V. โ€”
CIALIS
EU/1/02/237/1-5
Tadalafil Eli Lilly Nederland B.V. โ€”
Cialis 2.5 mg film-coated tablets
EU/1/02/237/006
Tadalafil Eli Lilly Nederland B.V. โ€”
Cialis 5 mg film-coated tablets
EU/1/02/237/7-8
Tadalafil Eli Lilly Nederland B.V. โ€”
Cymbalta 30 mg hard gastro-resistant capsules
EU/1/04/296/1-4
Duloxetine hydrochloride Eli Lilly Nederland B.V. โ€”
Cymbalta 60 mg hard gastro-resistant capsules
EU/1/04/296/002-005
Duloxetine Eli Lilly Nederland B.V. โ€”
Cyramza 10 mg/ml Concentrate for solution for infusion
EU/1/14/957/001-003
Ramucirumab Eli Lilly Nederland B.V. โ€”
Duloxetine Lilly 30 mg hard gastro-resistant capsules
EU/1/14/972/001-003
Duloxetine hydrochloride Eli Lilly Nederland B.V. โ€”
Duloxetine Lilly 60 mg hard gastro-resistant capsules
EU/1/14/972/005-009
Duloxetine hydrochloride Eli Lilly Nederland B.V. โ€”
Emgality
EU/1/18/1330/001-004
GALCANEZUMAB Eli Lilly Nederland B.V. โ€”
Forsteo 20 micrograms/80 microliters solution for injection in pre-filled pen
EU/1/03/247/01-2
Teriparatide Eli Lilly Nederland B.V. โ€”
Humalog
EU/1/96/007/019
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humalog 100 units/ml solution for injection in cartridge insulin lispro
EU/1/96/007/004
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humalog 100 units/ml solution for injection in vial
EU/1/96/007/002
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humalog Mix25 100 units/ml suspension for injection in cartridge
EU/1/96/007/008
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humalog Mix25 100 units/ml suspension for injection in vial
EU/1/96/007/005
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humalog Mix50 100 units/ml suspension for injection in cartridge
EU/1/96/007/006
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humalog NPL
EU/1/96/007/010
Insulin lispro Eli Lilly Nederland B.V. โ€”
Humulin I (Isophane) 100 IU/ml Suspension for Injection in cartridge
PA2276/002/004
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial
PA2276/002/003
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Not marketed
Humulin I KwikPen (Isophane) 100 IU/ml Suspension for Injection
PA2276/005/002
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge
PA2276/003/004
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in vial
PA2276/003/003
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Not marketed
Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection
PA2276/006/002
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin S (Soluble) 100 IU/ml Solution for Injection in vial
PA2276/001/003
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Not marketed
Humulin S (Soluble), 100 IU/ml Solution for Injection in cartridge
PA2276/001/004
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Jaypirca 100 mg film-coated tablets
EU/1/23/1738/004-009
Pirtobrutinib Eli Lilly Nederland B.V. โ€”
Jaypirca 50 mg film-coated tablets
EU/1/23/1738/001-003
Pirtobrutinib Eli Lilly Nederland B.V. โ€”
Kisunla 350 mg concentrate for solution for infusion
EU/1/25/1926/001-002
Donanemab Eli Lilly Nederland B.V. โ€”
Lartruvo
EU/1/16/1143/001
Olaratumab Eli Lilly Nederland B.V. โ€”
Liprolog
EU/1/01/195/22-27
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog 100 units/ml, solution for injection in vial
EU/1/01/195/001
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog 100 units/ml, solution for injection in vial
EU/1/01/195/002
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix25
EU/1/01/195/003
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix25 Pen
EU/1/01/195/006
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix50
EU/1/01/195/004
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog Mix50 Pen
EU/1/01/195/007
Insulin lispro Eli Lilly Nederland B.V. โ€”
Liprolog-Pen
EU/1/01/195/005
Insulin lispro Eli Lilly Nederland B.V. โ€”
Lyumjev
EU/1/20/1422/001-012
Insulin lispro Eli Lilly Nederland B.V. โ€”
Mounjaro 10 mg solution for injection in pre-filled pen
EU/1/22/1685/010-012
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 10 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/055-056
Tirzepatide Eli Lilly Nederland B.V. โ€”
1 2 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.